Simultaneous determination of antiepileptic drugs and their metabolites, including chiral compounds, via beta-cyclodextrin inclusion complexes by a column-switching chromatographic technique

J Chromatogr B Biomed Appl. 1994 Aug 19;658(2):385-90. doi: 10.1016/0378-4347(94)00246-0.

Abstract

Using beta-cyclodextrin as a mobile-phase additive, a column-switching chromatographic system equipped with two 25-mm short ODS cartridge columns and two UV detectors was successfully employed for the simultaneous determination of some antiepileptic drugs and their metabolites, including chiral compounds, in human serum. The compounds examined were phenobarbital, zonisamide, phenytoin and its metabolites, S- and R-5-(p-hydroxyphenyl)-5-phenylhydantoin, R- and S-mephobarbital, carbamazepine and its main metabolites, 10,11-dihydro-10-11-epoxycarbamazepine and trans-10,11-dihydroxy-10,11-dihydrocarbamazepine (as a racemate), and allobarbital (as an internal standard).

MeSH terms

  • Anticonvulsants / blood*
  • Chromatography
  • Cyclodextrins
  • Humans
  • Spectrophotometry, Ultraviolet
  • beta-Cyclodextrins*

Substances

  • Anticonvulsants
  • Cyclodextrins
  • beta-Cyclodextrins
  • betadex